The M1 and M2 paradigm of macrophage activation: Time for reassessment

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Martinez, Fernando O ^a   Gordon, Siamon ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD64 ANTIGEN; COLONY STIMULATING FACTOR 1; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; FICOLIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LECTIN; MYC PROTEIN; NITRIC OXIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; PROTEOGLYCAN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOPHAGY; CELL FUSION; CYTOKINE RELEASE; ENDOCYTOSIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PLEIOTROPY; T LYMPHOCYTE; TH2 CELL; VIRUS REPLICATION;

EID: 84897556094     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-13     Document Type: Article

References (109)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-57.
2. Coffman RL: Origins of the T(H)1-T(H)2 model: a personal perspective. Nat Immunol 2006, 7:539-41.
3. Mackaness GB: Cellular resistance to infection. J Exp Med 1962, 116:381-406.
4. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983, 158:670-89.
5. Pace JL, Russell SW, Schreiber RD, Altman A, Katz DH: Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma. Proc Natl Acad Sci USA 1983, 80:3782-6.
6. Celada A, Gray PW, Rinderknecht E, Schreiber RD: Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med 1984, 160:55-74.
7. Stein M, Keshav S, Harris N, Gordon S: Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992, 176:287-92.
8. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, Gordon S: Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol 1994, 24:1441-5.
9. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM: M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000, 164:6166-73.
10. Jenkins SJ, Allen JE: Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes. J Biomed Biotechnol 2010, 2010:262609.
11. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-86.
12. Verreck FAW, Boer T de, Langenberg DML, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, Waal-Malefyt R de, Ottenhoff THM: Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004, 101:4560-5.
13. Hu X, Ivashkiv LB: Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-50.
14. Waddell SJ, Popper SJ, Rubins KH, Griffiths MJ, Brown PO, Levin M, Relman DA: Dissecting interferon-induced transcriptional programs in human peripheral blood cells. PLoS ONE 2010, 5:e9753.
15. Martinez FO, Gordon S, Locati M, Mantovani A: Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006, 177:7303-11.
16. Nau GJ, Richmond JFL, Schlesinger A, Jennings EG, Lander ES, Young RA: Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 2002, 99:1503-8.
17. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M: Immune response in mice that lack the interferon-gamma receptor. Science 1993, 259:1742-5.
18. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993, 259:1739-42.
19. Marinho CRF, Nunez-Apaza LN, Martins-Santos R, Bastos KRB, Bombeiro AL, Bucci DZ, Sardinha LR, Lima MRD, Alvarez JM: IFNgamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Scand J Immunol 2007, 66:297-308.
20. Pinheiro RO, Rossi-Bergmann B: Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice. Mem Inst Oswaldo Cruz 2007, 102:79-82.
21. Jakobi V, Petry F: Humoral immune response in IL-12 and IFNgamma deficient mice after infection with Cryptosporidium parvum. Parasite Immunol 2008, 30:151-61.
22. Saeftel M, Arndt M, Specht S, Volkmann L, Hoerauf A: Synergism of gamma interferon and interleukin-5 in the control of murine filariasis. Infect Immun 2003, 71:6978-85.
23. Rezende SA, Oliveira VR, Silva AM, Alves JB, Goes AM, Reis LF: Mice lacking the gamma interferon receptor have an impaired granulomatous reaction to Schistosoma mansoni infection. Infect Immun 1997, 65:3457-61.
24. Du X, Wu J, Zhang M, Gao Y, Zhang D, Hou M, Ji M, Wu G: Upregulated expression of cytotoxicity-related genes in IFN-g knockout mice with Schistosoma japonicum infection. J Biomed Biotechnol 2011, 2011:864945.
25. Dorman SE, Holland SM: Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000, 11:321-33.
26. Mukhopadhyay S, Chen Y, Sankala M, Peiser L, Pikkarainen T, Kraal G, Tryggvason K, Gordon S: MARCO, an innate activation marker of macrophages, is a class A scavenger receptor for Neisseria meningitidis. Eur J Immunol 2006, 36:940-9.
27. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszynski A, Forsberg LS, Carlson RW, Dixit VM: Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013, 341:1246-9.
28. Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA: Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 2013, 341:1250-3.
29. Takeda K, Akira S: TLR signaling pathways. Semin Immunol 2004, 16:3-9.
30. Yamamoto M, Takeda K: Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract 2010, 2010:240365.
31. Kawai T, Akira S: Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-50.
32. Netea MG, Wijmenga C, O'Neill LAJ: Genetic variation in Tolllike receptors and disease susceptibility. Nat Immunol 2012, 13:535-42.
33. Casanova J, Abel L, Quintana-Murci L: Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol 2011, 29:447-91.
34. Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J, Ramshaw H, Woodcock JM, Xu Y, Guthridge M, McKinstry WJ, Lopez AF, Parker MW: The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008, 134:496-507.
35. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA: IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 2011, 12:231-8.
36. Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, Julkunen I: Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J Leukoc Biol 2007, 82:710-20.
37. Dranoff G, Mulligan RC: Activities of granulocyte-macrophage colony-stimulating factor revealed by gene transfer and gene knockout studies. Stem Cells 1994, 12 (Suppl 1):173-82; discussion 182-4.
38. Dirksen U, Nishinakamura R, Groneck P, Hattenhorst U, Nogee L, Murray R, Burdach S: Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 1997, 100:2211-7.
39. Dirksen U, Hattenhorst U, Schneider P, Schroten H, Gobel U, Bocking A, Müller KM, Murray R, Burdach S: Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood 1998, 92:1097-103.
40. Martinez FO, Helming L, Milde R, Varin A, Melgert BN, Draijer C, Thomas B, Fabbri M, Crawshaw A, Ho LP, Hacken NH ten, Cobos Jimenez V, Kootstra NA, Hamann J, Greaves DR, Locati M, Mantovani A, Gordon S: Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood 2013, 121:e57-69.
41. Scotton CJ, Martinez FO, Smelt MJ, Sironi M, Locati M, Mantovani A, Sozzani S: Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13. J Immunol 2005, 174:834-45.
42. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009, 27:451-83.
43. van Dyken SJ, Locksley RM: Interleukin-4-and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 2013, 31:317-43.
44. Ford AQ, Heller NM, Stephenson L, Boothby MR, Keegan AD: An atopy-associated polymorphism in the ectodomain of the IL-4R(alpha) chain (V50) regulates the persistence of STAT6 phosphorylation. J Immunol 2009, 183:1607-16.
45. Beghe B, Barton S, Rorke S, Peng Q, Sayers I, Gaunt T, Keith TP, Clough JB, Holgate ST, Holloway JW: Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population. Clin Exp Allergy 2003, 33:1111-7.
46. Edwards JP, Zhang X, Frauwirth KA, Mosser DM: Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006, 80:1298-307.
47. Anderson CF, Mosser DM: A novel phenotype for an activated macrophage: the type 2 activated macrophage. J Leukoc Biol 2002, 72:101-6.
48. Sironi M, Martinez FO, D'Ambrosio D, Gattorno M, Polentarutti N, Locati M, Gregorio A, Iellem A, Cassatella MA, van Damme J, Sozzani S, Martini A, Sinigaglia F, Vecchi A, Mantovani A: Differential regulation of chemokine production by Fcgamma receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol 2006, 80:342-9.
49. Sanchez-Mejorada G, Rosales C: Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol 1998, 63:521-33.
50. Takai T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol 2002, 2:580-92.
51. Ehrchen J, Steinmüller L, Barczyk K, Tenbrock K, Nacken W, Eisenacher M, Nordhues U, Sorg C, Sunderkotter C, Roth J: Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 2007, 109:1265-74.
52. van de Garde MDB, Martinez FO, Melgert BN, Hylkema MN, Jonkers RE, Hamann J: Chronic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macrophages with distinct changes in leukocyte attraction. J Immunol 2014, 192:1196-208.
53. Kleiman A, Hübner S, Rodriguez Parkitna JM, Neumann A, Hofer S, Weigand MA, Bauer M, Schmid W, Schütz G, Libert C, Reichardt HM, Tuckermann JP: Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J 2012, 26:722-9.
54. Bray PJ, Cotton RGH: Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 2003, 21:557-68.
55. Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989, 170:2081-95.
56. Park-Min K, Antoniv TT, Ivashkiv LB: Regulation of macrophage phenotype by long-term exposure to IL-10. Immunobiology 2005, 210:77-86.
57. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB: Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998, 66:5224-31.
58. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A: In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 1996, 157:798-805.
59. Glocker E, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, Hatscher N, Pfeifer D, Sykora K, Sauer M, Kreipe H, Lacher M, Nustede R, Woellner C, Baumann U, Salzer U, Koletzko S, Shah N, Segal AW, Sauerbrey A, Buderus S, Snapper SB, Grimbacher B, Klein C: Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 2009, 361:2033-45.
60. Hashimoto S, Suzuki T, Dong HY, Yamazaki N, Matsushima K: Serial analysis of gene expression in human monocytes and macrophages. Blood 1999, 94:837-44.
61. Lacey DC, Achuthan A, Fleetwood AJ, Dinh H, Roiniotis J, Scholz GM, Chang MW, Beckman SK, Cook AD, Hamilton JA: Defining GM-CSF-and macrophage-CSF- dependent macrophage responses by in vitro models. J Immunol 2012, 188:5752-65.
62. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER: Total absence of colonystimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990, 87:4828-32.
63. Tobal K, Pagliuca A, Bhatt B, Bailey N, Layton DM, Mufti GJ: Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 1990, 4:486-9.
64. Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cairns NJ, Ghetti B, Spina S, Garbern J, Tselis AC, Uitti R, Das P, van Gerpen JA, Meschia JF, et al.: Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2012, 44:200-5.
65. Etzrodt M, Cortez-Retamozo V, Newton A, Zhao J, Ng A, Wildgruber M, Romero P, Wurdinger T, Xavier R, Geissmann F, Meylan E, Nahrendorf M, Swirski FK, Baltimore D, Weissleder R, Pittet MJ: Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep 2012, 1:317-24.
66. Graff JW, Dickson AM, Clay G, McCaffrey AP, Wilson ME: Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem 2012, 287:21816-25.
67. Lagrange B, Martin RZ, Droin N, Aucagne R, Paggetti J, Largeot A, Itzykson R, Solary E, Delva L, Bastie J: A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages. Biochim Biophys Acta 2013, 1833:1936-46.
68. Mildner A, Chapnik E, Manor O, Yona S, Kim K, Aychek T, Varol D, Beck G, Itzhaki ZB, Feldmesser E, Amit I, Hornstein E, Jung S: Mononuclear phagocyte miRNomeanalysis identifies miR-142 as critical regulator of murine dendritic cell homeostasis. Blood 2013, 121:1016-27.
69. Swaminathan S, Hu X, Zheng X, Kriga Y, Shetty J, Zhao Y, Stephens R, Tran B, Baseler MW, Yang J, Lempicki RA, Huang D, Lane HC, Imamichi T: Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate antiviral properties. Biochem Biophys Res Commun 2013, 434:228-34.
70. Santa F de, Barozzi I, Mietton F, Ghisletti S, Polletti S, Tusi BK, Muller H, Ragoussis J, Wei C, Natoli G: A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 2010, 8: e1000384.
71. Kaikkonen MU, Lam MTY, Glass CK: Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011, 90:430-40.
72. Lam MTY, Cho H, Lesch HP, Gosselin D, Heinz S, Tanaka-Oishi Y, Benner C, Kaikkonen MU, Kim AS, Kosaka M, Lee CY, Watt A, Grossman TR, Rosenfeld MG, Evans RM, Glass CK: Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013, 498:511-5.
73. Bowdridge S, Gause WC: Regulation of alternative macrophage activation by chromatin remodeling. Nat Immunol 2010, 11:879-81.
74. Lawrence T, Natoli G: Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011, 11:750-61.
75. Ivashkiv LB: Epigenetic regulation of macrophage polarization and function. Trends Immunol 2013, 34:216-23.
76. Mukhopadhyay S, Ramadass AS, Akoulitchev A, Gordon S: Formation of distinct chromatin conformation signatures epigenetically regulate macrophage activation. Int Immunopharmacol 2013, 18:7-11.
77. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, Nakai K, Akira S: The Jmjd3-Irf4 axis regulatesM2macrophage polarization and host responses against helminth infection. Nat Immunol 2010, 11:936-44.
78. Kruidenier L, Chung C, Cheng Z, Liddle J, Che K, Joberty G, Bantscheff M, Bountra C, Bridges A, Diallo H, Eberhard D, Hutchinson S, Jones E, Katso R, Leveridge M, Mander PK, Mosley J, Ramirez-Molina C, Rowland P, Schofield CJ, Sheppard RJ, Smith JE, Swales C, Tanner R, Thomas P, Tumber A, Drewes G, Oppermann U, Patel DJ, Lee K, et al.: A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 2012, 488:404-8.
79. Davies LC, Jenkins SJ, Allen JE, Taylor PR: Tissue-resident macrophages. Nat Immunol 2013, 14:986-95.
80. Madore A, Perron S, Turmel V, Laviolette M, Bissonnette EY, Laprise C: Alveolar macrophages in allergic asthma: an expression signature characterized by heat shock protein pathways. Hum Immunol 2010, 71:144-50.
81. Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey B, O'Connor TP, Crystal RG: Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 2009, 183:2867-83.
82. Feig JE, Vengrenyuk Y, Reiser V, Wu C, Statnikov A, Aliferis CF, Garabedian MJ, Fisher EA, Puig O: Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS ONE 2012, 7:e39790.
83. Ojalvo LS, Whittaker CA, Condeelis JS, Pollard JW: Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 2010, 184:702-12.
84. Murray PJ, Wynn TA: Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11:723-37.
85. Pettersen JS, Fuentes-Duculan J, Suarez-Farinas M, Pierson KC, Pitts-Kiefer A, Fan L, Belkin DA, Wang CQF, Bhuvanendran S, Johnson-Huang LM, Bluth MJ, Krueger JG, Lowes MA, Carucci JA: Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol 2011, 131:1322-30.
86. Vogel DYS, Vereyken EJF, Glim JE, Heijnen PDAM, Moeton M, van der Valk P, Amor S, Teunissen CE, van Horssen J, Dijkstra CD: Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation 2013, 10:35.
87. Odegaard JI, Chawla A: Alternative macrophage activation and metabolism. Annu Rev Pathol 2011, 6:275-97.
88. Ricote M, Valledor AF, Glass CK: Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 2004, 24:230-9.
89. Cunard R, Ricote M, DiCampli D, Archer DC, Kahn DA, Glass CK, Kelly CJ: Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J Immunol 2002, 168:2795-802.
90. Palsson-McDermott EM, O'Neill LAJ: The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays 2013, 35:965-73.
91. Zhu J, Paul WE: Heterogeneity and plasticity of T helper cells. Cell Res 2010, 20:4-12.
92. Tamassia N, Le Moigne V, Calzetti F, Donini M, Gasperini S, Ear T, Cloutier A, Martinez FO, Fabbri M, Locati M, Mantovani A, McDonald PP, Cassatella MA: The MyD88-independent pathway is not mobilized in human neutrophils stimulated via TLR4. J Immunol 2007, 178:7344-56.
93. Mazzoni A, Segal DM: Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 2004, 75:721-30.
94. Kapsenberg ML: Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003, 3:984-93.
95. Marodi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB: Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 1993, 91:2596-601.
96. Frausto-Del-Rio D, Soto-Cruz I, Garay-Canales C, Ambriz X, Soldevila G, Carretero-Ortega J, Vazquez-Prado J, Ortega E: Interferon gamma induces actin polymerization, Rac1 activation and down regulates phagocytosis in human monocytic cells. Cytokine 2012, 57:158-68.
97. Schlesinger LS, Horwitz MA: Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol 1991, 147:1983-94.
98. Varin A, Mukhopadhyay S, Herbein G, Gordon S: Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 2010, 115:353-62.
99. Matsuzawa T, Kim B, Shenoy AR, Kamitani S, Miyake M, Macmicking JD: IFN-g elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol 2012, 189:813-8.
100. Harris J, Haro SA de, Master SS, Keane J, Roberts EA, Delgado M, Deretic V: T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007, 27:505-17.
101. Takashima T, Ohnishi K, Tsuyuguchi I, Kishimoto S: Differential regulation of formation of multinucleated giant cells from concanavalin A-stimulated human blood monocytes by IFNgamma and IL-4. J Immunol 1993, 150:3002-10.
102. Nagasawa H, Miyaura C, Abe E, Suda T, Horiguchi M: Fusion and activation of human alveolar macrophages induced by recombinant interferon-gamma and their suppression by dexamethasone. Am Rev Respir Dis 1987, 136:916-21.
103. Helming L, Gordon S: Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules. Eur J Immunol 2007, 37:33-42.
104. Herbst S, Schaible UE, Schneider BE: Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS ONE 2011, 6:e19105.
105. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, Thompson RW, Cheever AW, Murray PJ, Wynn TA: Arginase-1-expressing macrophages suppress Th2 cytokinedriven inflammation and fibrosis. PLoS Pathog 2009, 5:e1000371.
106. Thomas GR, McCrossan M, Selkirk ME: Cytostatic and cytotoxic effects of activated macrophages and nitric oxide donors on Brugia malayi. Infect Immun 1997, 65:2732-9.
107. Piedrafita D, Parsons JC, Sandeman RM, Wood PR, Estuningsih SE, Partoutomo S, Spithill TW: Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates. Parasite Immunol 2001, 23:473-82.
108. Urban JF, Noben-Trauth N, Schopf L, Madden KB, Finkelman FD: Cutting edge: IL-4 receptor expression by non-bone marrowderived cells is required to expel gastrointestinal nematode parasites. J Immunol 2001, 167:6078-81.
109. Cassol E, Cassetta L, Rizzi C, Alfano M, Poli G: M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol 2009, 182:6237-46.